The University of Chicago Header Logo

Russell D. Cohen

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Gastroenterology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zinger A, Choi D, Choi N, Fear E, Fine Z, Cohen RD, Rubin DT. Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn's Disease from a Large Tertiary Center. Clin Gastroenterol Hepatol. 2024 Oct 24. PMID: 39461462.
      Citations:    Fields:    
    2. Akiyama S, Cohen NA, Ollech JE, Traboulsi C, Rodriguez T, Rai V, Glick LR, Yi Y, Runde J, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. A Comparative Analysis of Clinical Symptoms and Modified Pouchitis Disease Activity Index Among Endoscopic Phenotypes of the J Pouch in Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2024 Jul; 6(3):otae045. PMID: 39347443; PMCID: PMC11438232.
      Citations:    
    3. Akiyama S, Ollech JE, Cohen NA, Traboulsi C, Rai V, Glick LR, Yi Y, Runde J, Cohen RD, Olortegui KBS, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 Jun 25. PMID: 38916136.
      Citations: 1     Fields:    
    4. Cohen NA, Choi D, Garcia N, Choi NK, Picker E, Krugliak Cleveland N, Cohen RD, Dalal SR, Pekow J, Rubin DT. Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center. Dig Dis Sci. 2024 Feb; 69(2):579-587. PMID: 38087126.
      Citations: 1     Fields:    Translation:Humans
    5. Zinger A, Choi D, Choi N, Cohen RD, Rubin DT. Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2024 Jun; 22(6):1336-1338.e2. PMID: 38065372.
      Citations: 1     Fields:    Translation:Humans
    6. Paknikar R, Alpert L, Cohen RD, Shogan B, Micic D. Digging into the Histology. N Engl J Med. 2023 Oct 05; 389(14):1321-1326. PMID: 37792616; PMCID: PMC10699882.
      Citations:    Fields:    
    7. Choi DK, Cohen NA, Choden T, Cohen RD, Rubin DT. Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 10 03; 29(10):1658-1661. PMID: 36715294.
      Citations: 3     Fields:    Translation:Humans
    8. Jamil OK, Shaw D, Deng Z, Dinardi N, Fillman N, Khanna S, Krugliak Cleveland N, Sakuraba A, Weber CR, Cohen RD, Dalal S, Jabri B, Rubin DT, Pekow J. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis. Therap Adv Gastroenterol. 2023; 16:17562848231184985. PMID: 37692199; PMCID: PMC10486214.
      Citations:    
    9. Shaw DG, Aguirre-Gamboa R, Vieira MC, Gona S, DiNardi N, Wang A, Dumaine A, Gelderloos-Arends J, Earley ZM, Meckel KR, Ciszewski C, Castillo A, Monroe K, Torres J, Shah SC, Colombel JF, Itzkowitz S, Newberry R, Cohen RD, Rubin DT, Quince C, Cobey S, Jonkers IH, Weber CR, Pekow J, Wilson PC, Barreiro LB, Jabri B. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat Med. 2023 Jun; 29(6):1520-1529. PMID: 37322120; PMCID: PMC10287559.
      Citations: 5     Fields:    Translation:Humans
    10. Choden T, Cohen RD. Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis. Dig Dis Sci. 2023 06; 68(6):2248-2251. PMID: 37029877.
      Citations:    Fields:    Translation:Humans
    11. Friedberg S, Choi D, Hunold T, Choi NK, Garcia NM, Picker EA, Cohen NA, Cohen RD, Dalal SR, Pekow J, Sakuraba A, Krugliak Cleveland N, Rubin DT. Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience. Clin Gastroenterol Hepatol. 2023 07; 21(7):1913-1923.e2. PMID: 36898598; PMCID: PMC11016252.
      Citations: 20     Fields:    Translation:Humans
    12. Jairath V, Cohen RD, Loftus EV, Candela N, Lasch K, Schultz BG. Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis. BMC Gastroenterol. 2022 Dec 06; 22(1):501. PMID: 36474165; PMCID: PMC9724317.
      Citations:    Fields:    
    13. Cohen NA, Steinberg JM, Silfen A, Traboulsi C, Rodriguez TG, Singer JM, Patel S, Cohen RD, Dalal SR, Sakuraba A, Pekow J, Micic D, Rubin DT. Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes. Dig Dis Sci. 2023 04; 68(4):1464-1472. PMID: 36242686.
      Citations: 2     Fields:    Translation:Humans
    14. Choden T, Yeager M, Cohen RD. Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis. Dig Dis Sci. 2022 11; 67(11):5010-5013. PMID: 36098874.
      Citations:    Fields:    Translation:Humans
    15. Runde J, Erondu A, Akiyama S, Traboulsi C, Rai V, Glick LR, Yi Y, Ollech JE, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis. Inflamm Bowel Dis. 2022 09 01; 28(9):1386-1394. PMID: 35040964; PMCID: PMC9434476.
      Citations: 4     Fields:    Translation:Humans
    16. Cohen NA, Zafer M, Setia N, Anderson MJ, Sakuraba A, Dalal S, Pekow J, Cohen RD, Rubin DT, Micic D. Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis. Dig Dis Sci. 2023 03; 68(3):897-901. PMID: 35781654.
      Citations: 1     Fields:    Translation:HumansCells
    17. Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. Gastroenterology. 2022 07; 163(1):204-221. PMID: 35413359.
      Citations: 12     Fields:    Translation:Humans
    18. Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2023 08; 21(9):2407-2409.e2. PMID: 35381385; PMCID: PMC11009929.
      Citations: 3     Fields:    Translation:Humans
    19. Akiyama S, Ollech JE, Traboulsi C, Rai V, Glick LR, Yi Y, Runde J, Olivas AD, Weber CR, Cohen RD, Olortegui KBS, Hurst RD, Umanskiy K, Shogan BD, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Hart J, Hyman NH, Rubin DT. Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis. Dig Dis Sci. 2022 08; 67(8):4020-4031. PMID: 35288827; PMCID: PMC10966959.
      Citations: 3     Fields:    Translation:Humans
    20. Akiyama S, Cohen NA, Steinberg JM, Friedberg S, Cohen RD. Rare and Well Done: Endoscopic Control of Colonic Hemorrhage in Severe Ulcerative Colitis. Dig Dis Sci. 2022 03; 67(3):805-809. PMID: 35257245.
      Citations:    Fields:    Translation:Humans
    21. Ayoub F, Odenwald M, Micic D, Dalal SR, Pekow J, Cohen RD, Rubin DT, Sakuraba A. Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis. Intest Res. 2022 Apr; 20(2):240-250. PMID: 35124951; PMCID: PMC9081994.
      Citations: 8     
    22. Zafer M, Zhang H, Dwadasi S, Goens D, Paknikar R, Dalal S, Cohen RD, Pekow J, Rubin DT, Sakuraba A, Micic D. A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis. Crohns Colitis 360. 2022 Jan; 4(1):otab082. PMID: 36777555; PMCID: PMC9802419.
      Citations: 1     
    23. Long MD, Cohen RD, Smith TW, DiBonaventura M, Gruben D, Bargo D, Salese L, Quirk D. Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis. Dig Dis. 2022; 40(5):553-564. PMID: 34879378; PMCID: PMC9501753.
      Citations: 3     Fields:    Translation:Humans
    24. Dwadasi S, Zafer M, Goens D, Paknikar R, Dalal S, Cohen RD, Pekow J, Rubin DT, Sakuraba A, Micic D. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1620-1625. PMID: 33319248; PMCID: PMC8682443.
      Citations: 5     Fields:    Translation:Humans
    25. Buisson A, Cannon L, Umanskiy K, Hurst RD, Hyman NH, Sakuraba A, Pekow J, Dalal S, Cohen RD, Pereira B, Rubin DT. Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease. Intest Res. 2022 Jul; 20(3):303-312. PMID: 34333909; PMCID: PMC9344250.
      Citations: 7     
    26. Buisson A, Mak WY, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Rubin DT, Pereira B. Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. Inflamm Bowel Dis. 2021 06 15; 27(7):1008-1016. PMID: 33107563; PMCID: PMC8600021.
      Citations: 15     Fields:    Translation:Humans
    27. Akiyama S, Yamada A, Ollech JE, Komaki Y, Komaki F, Pekow J, Dalal SR, Cohen RD, Rubin DT, Sakuraba A. Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's disease. J Gastroenterol Hepatol. 2021 Oct; 36(10):2785-2793. PMID: 33973282.
      Citations: 3     Fields:    Translation:Humans
    28. Salem G, Ding K, Sakuraba A, Cohen R. Role of topical tacrolimus in the management of proctitis, perianal manifestations in Crohn's disease, and chronic pouchitis: a systematic review. J Investig Med. 2021 Feb 23. PMID: 33622709.
      Citations: 4     Fields:    
    29. Yamada A, Komaki Y, Komaki F, Haider H, Micic D, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Shogan BD, Hurst R, Hyman N, Rubin DT, Sakuraba A. The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's Disease. Digestion. 2021; 102(5):767-775. PMID: 33556932.
      Citations: 8     Fields:    Translation:Humans
    30. Cohen RD, Feuerstein JD, Rubin DT. Reply. Gastroenterology. 2021 06; 160(7):2627. PMID: 33561439; PMCID: PMC7867470.
      Citations:    Fields:    
    31. Akiyama S, Ollech JE, Rai V, Glick LR, Yi Y, Traboulsi C, Runde J, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes. Clin Gastroenterol Hepatol. 2022 02; 20(2):293-302.e9. PMID: 33549868; PMCID: PMC8339185.
      Citations: 15     Fields:    Translation:Humans
    32. Patel P, Gao G, Gulotta G, Dalal S, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 01 19; 27(2):236-241. PMID: 32219391; PMCID: PMC7813746.
      Citations: 6     Fields:    Translation:Humans
    33. Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ, Crohn’s Colitis Foundation Clinical Research Alliance. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology. 2021 03; 160(4):1131-1139. PMID: 33227283; PMCID: PMC7956164.
      Citations: 61     Fields:    Translation:Humans
    34. Ollech JE, Avni-Biron I, Glick L, Haider H, Dalal SR, Micic D, Pekow J, Yanai H, Cohen RD, Dotan I, Rubin DT, Sakuraba A. Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes. Clin Gastroenterol Hepatol. 2021 11; 19(11):2444-2446.e2. PMID: 33223497.
      Citations: 4     Fields:    Translation:Humans
    35. Hron BM, Cohen RD, Johnson SJ, Skup M, Chao J, Kahn SA. Letter: is unrealised adult height resulting from paediatric Crohn's disease associated with a potential reduction in lifetime earnings? Aliment Pharmacol Ther. 2020 08; 52(3):559-560. PMID: 32656841.
      Citations:    Fields:    Translation:Humans
    36. Berger M, Yamada A, Komaki Y, Komaki F, Cohen RD, Dalal S, Hurst RD, Hyman N, Pekow J, Shogan BD, Umanskiy K, Rubin DT, Sakuraba A, Micic D. Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications. Crohns Colitis 360. 2020 Jul; 2(3):otaa064. PMID: 36776498; PMCID: PMC9802466.
      Citations: 6     
    37. Ollech JE, Normatov I, Peleg N, Dalal SR, Pekow J, Micic D, Cohen RD, Rubin DT, Sakuraba A. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116. PMID: 32710391.
      Citations: 1     Fields:    Translation:Humans
    38. Wang J, Prenner J, Wang W, Sakuraba A, Hyman N, Dalal S, Hurst R, Cohen RD, Umanskiy K, Shogan BD, Alpert L, Rubin DT, Colwell J, Pekow J. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020 06; 51(12):1365-1372. PMID: 32383278.
      Citations: 4     Fields:    Translation:Humans
    39. Rubin DT, Feuerstein JD, Wang AY, Cohen RD. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology. 2020 Jul; 159(1):350-357. PMID: 32283100; PMCID: PMC7151253.
      Citations: 135     Fields:    Translation:HumansCellsPHPublic Health
    40. Ollech JE, Normatov I, Peleg N, Wang J, Patel SA, Rai V, Yi Y, Singer J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2021 01; 19(1):104-110. PMID: 32109634; PMCID: PMC8665415.
      Citations: 32     Fields:    Translation:Humans
    41. Cohen RD, Bhayat F, Blake A, Travis S. The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data. J Crohns Colitis. 2020 Feb 10; 14(2):192-204. PMID: 31504340.
      Citations: 29     Fields:    Translation:Humans
    42. Cohen RD, Weisshof R. A Comprehensive Review of Topical Therapies for Distal Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2020 Jan; 16(1):21-27. PMID: 33867885; PMCID: PMC8040904.
      Citations: 4     
    43. Ollech JE, Dwadasi S, Rai V, Peleg N, Normatov I, Israel A, Sossenheimer PH, Christensen B, Pekow J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2020 03; 51(6):637-643. PMID: 31875986.
      Citations: 25     Fields:    Translation:Humans
    44. Glick LR, Sossenheimer PH, Ollech JE, Cohen RD, Hyman NH, Hurst RD, Rubin DT. Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study. J Crohns Colitis. 2019 Sep 19; 13(9):1158-1162. PMID: 30809655; PMCID: PMC6939874.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    45. Weisshof R, Ollech JE, El Jurdi K, Yvellez OV, Cohen RD, Sakuraba A, Dalal S, Pekow J, Rubin DT. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe. J Crohns Colitis. 2019 Sep 19; 13(9):1105-1110. PMID: 30726894; PMCID: PMC7327272.
      Citations: 13     Fields:    Translation:Humans
    46. Buisson A, Mak WY, Andersen MJ, Lei D, Kahn SA, Pekow J, Cohen RD, Zmeter N, Rubin DT, Pereira B. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2019 Aug 14; 13(8):1012-1024. PMID: 30726887; PMCID: PMC6939876.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    47. Wang Y, Wang J, Pekow J, Dalal S, Cohen RD, Ollech J, Israel A, Shogan BD, Micic D, Cannon L, Umanskiy K, Hurst R, Hyman N, Rubin DT, Sakuraba A. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095. PMID: 31169926.
      Citations: 6     Fields:    Translation:Humans
    48. Israel A, Christensen B, El Jurdi K, Rai V, Ollech JE, Cohen RD, Sakuraba A, Dalal SR, Rubin DT. Follow-Up of Patients With Ulcerative Colitis and Histological Normalization. Clin Gastroenterol Hepatol. 2020 04; 18(4):987-988.e1. PMID: 31228567; PMCID: PMC6923607.
      Citations: 2     Fields:    Translation:Humans
    49. Ollech JE, Rubin DT, Glick L, Weisshof R, El Jurdi K, Israel A, Krugliak Cleveland N, Hyman N, Sakuraba A, Pekow J, Cohen RD, Dalal SR. Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Dig Dis Sci. 2019 12; 64(12):3596-3601. PMID: 31187322; PMCID: PMC6858501.
      Citations: 24     Fields:    Translation:Humans
    50. Alpert L, Yassan L, Poon R, Kadri S, Niu N, Patil SA, Mujacic I, Montes D, Galbo F, Wurst MN, Zhen CJ, Cohen RD, Rubin DT, Pekow JR, Weber CR, Xiao SY, Hart J, Segal J, Setia N. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Hum Pathol. 2019 07; 89:44-50. PMID: 31054900.
      Citations: 11     Fields:    Translation:Humans
    51. Lu TX, Cohen RD. Maneuvering Clinical Pathways for Crohn's Disease. Curr Gastroenterol Rep. 2019 Apr 23; 21(5):20. PMID: 31016466; PMCID: PMC11225067.
      Citations:    Fields:    Translation:Humans
    52. Sossenheimer PH, Glick LR, Dachman AH, Skowron KB, Rubin MA, Umanskiy K, Smith R, Cannon LM, Hurst RD, Cohen RD, Hyman NH, Rubin DT. Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients. Dis Colon Rectum. 2019 04; 62(4):463-469. PMID: 30540661.
      Citations: 10     Fields:    Translation:Humans
    53. Weisshof R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, Ollech JE, Pekow J, Cohen RD, Sakuraba A, Dalal S, Rubin DT. Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Dig Dis Sci. 2019 07; 64(7):1945-1951. PMID: 30734234; PMCID: PMC6935176.
      Citations: 36     Fields:    Translation:Humans
    54. Ollech JE, Aharoni-Golan M, Weisshof R, Normatov I, Sapp AR, Kalakonda A, Israel A, Glick LR, Karrison T, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease. Gastrointest Endosc. 2019 08; 90(2):269-275. PMID: 30738034; PMCID: PMC6774247.
      Citations: 13     Fields:    Translation:Humans
    55. Frohne CC, Llano EM, Perkovic A, Cohen RD, Luke JJ. Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-a4ß7 and anti-PD1 antibodies. J Immunother Cancer. 2019 01 06; 7(1):1. PMID: 30612589; PMCID: PMC6322234.
      Citations: 22     Fields:    Translation:Humans
    56. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT. Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 10; 63(10):2815. PMID: 30136047.
      Citations:    Fields:    
    57. Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther. 2018 11; 48(9):933-940. PMID: 30126019; PMCID: PMC6669906.
      Citations: 4     Fields:    Translation:Humans
    58. Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan JG, Safdi M, Nissinen R, Sandborn WJ, Cohen RD, Taillard F. Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. Am J Gastroenterol. 2018 11; 113(11):1678-1688. PMID: 30022113.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    59. Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol. 2018 07; 52(6):537-544. PMID: 28723860.
      Citations: 7     Fields:    Translation:HumansCells
    60. Patel P, Yarur A, Dalal S, Sakuraba A, Rubin DT, Hanauer SB, Hanan I, Raffals LH, Cohen RD, Pekow J. Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy. Inflamm Bowel Dis. 2018 05 18; 24(6):1291-1297. PMID: 29506124; PMCID: PMC7190889.
      Citations:    Fields:    Translation:Humans
    61. Krugliak Cleveland N, Ollech JE, Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Hurst R, Rubin DT. Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia. Clin Gastroenterol Hepatol. 2019 01; 17(1):205-206. PMID: 29751167; PMCID: PMC7034413.
      Citations: 12     Fields:    Translation:Humans
    62. Christensen B, Gibson PR, Micic D, Colman RJ, Goeppinger SR, Kassim O, Yarur A, Weber CR, Cohen RD, Rubin DT. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493. PMID: 29751166; PMCID: PMC7034423.
      Citations: 35     Fields:    Translation:Humans
    63. Christensen B, Colman RJ, Micic D, Gibson PR, Goeppinger SR, Yarur A, Weber CR, Cohen RD, Rubin DT. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860. PMID: 29562271; PMCID: PMC6196763.
      Citations: 15     Fields:    Translation:Humans
    64. Mak WY, Buisson A, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Rubin DT, Pereira B. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci. 2018 May; 63(5):1294-1301. PMID: 29468374.
      Citations: 27     Fields:    Translation:Humans
    65. Yamada A, Komaki Y, Patel N, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):502-509. PMID: 29462385.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    66. Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Safdi M, Popp JW, Langholff W, Sandborn WJ. Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience. Inflamm Bowel Dis. 2018 02 15; 24(3):490-501. PMID: 29462395; PMCID: PMC6176880.
      Citations: 52     Fields:    Translation:Humans
    67. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024. PMID: 29417331.
      Citations: 5     Fields:    Translation:HumansCells
    68. Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc. 2018 May; 87(5):1304-1309. PMID: 29307473; PMCID: PMC9646239.
      Citations: 4     Fields:    Translation:Humans
    69. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 12 04; 11(12):1510. PMID: 28453665; PMCID: PMC5951008.
      Citations:    Fields:    
    70. Cohen RD. Nonmedical Switching of Biosimilars in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Nov; 13(11):697-699. PMID: 29230150; PMCID: PMC5717886.
      Citations: 2     
    71. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):99-105. PMID: 28870657; PMCID: PMC5735029.
      Citations: 39     Fields:    Translation:HumansCells
    72. Micic D, Gaetano JN, Rubin JN, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900. PMID: 28837634; PMCID: PMC5570509.
      Citations: 17     Fields:    Translation:Humans
    73. Yamada A, Komaki Y, Patel N, Komaki F, Aelvoet AS, Tran AL, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab. Am J Gastroenterol. 2017 Sep; 112(9):1423-1429. PMID: 28719595.
      Citations: 34     Fields:    Translation:Humans
    74. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 Jul 01; 11(7):785-791. PMID: 28333362; PMCID: PMC5881669.
      Citations: 26     Fields:    Translation:Humans
    75. Meckel K, Li YC, Lim J, Kocherginsky M, Weber C, Almoghrabi A, Chen X, Kaboff A, Sadiq F, Hanauer SB, Cohen RD, Kwon J, Rubin DT, Hanan I, Sakuraba A, Yen E, Bissonnette M, Pekow J. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr. 2016 07; 104(1):113-20. PMID: 27281309; PMCID: PMC4919525.
      Citations: 41     Fields:    Translation:Humans
    76. Saad AM, Czul F, Sakuraba A, Rubin DT, Cohen RD. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease. Inflamm Bowel Dis. 2016 May; 22(5):1027-31. PMID: 26919459.
      Citations: 7     Fields:    Translation:Humans
    77. Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Rubin DT, Krugliak Cleveland N. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis. 2016 Mar; 22(3):631-7. PMID: 26658214; PMCID: PMC5058785.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    78. Komaki Y, Komaki F, Sakuraba A, Cohen R. Approach to Optimize Anti-TNF-a Therapy in Patients With IBD. Curr Treat Options Gastroenterol. 2016 Mar; 14(1):83-90. PMID: 26872815.
      Citations: 10     
    79. Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U. The Effect of Maternal Peripartum Anti-TNFa Use on Infant Immune Response. Dig Dis Sci. 2016 06; 61(6):1622-7. PMID: 26725061.
      Citations: 12     Fields:    Translation:Humans
    80. Dalal SR, Cohen RD. What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients. Gastroenterol Hepatol (N Y). 2015 Oct; 11(10):657-65. PMID: 27330493; PMCID: PMC4849518.
      Citations: 18     
    81. Cohen RD, Dalal SR. Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis. Inflamm Bowel Dis. 2015 Jul; 21(7):1719-36. PMID: 26020604.
      Citations: 14     Fields:    Translation:Humans
    82. Dassopoulos T, Cohen RD, Scherl EJ, Schwartz RM, Kosinski L, Regueiro MD. Ulcerative Colitis Care Pathway. Gastroenterology. 2015 Jul; 149(1):238-45. PMID: 26025078.
      Citations: 40     Fields:    Translation:Humans
    83. Bellaguarda E, Keyashian K, Pekow J, Rubin DT, Cohen RD, Sakuraba A. Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1919-25. PMID: 26001336; PMCID: PMC4795937.
      Citations: 10     Fields:    Translation:HumansCells
    84. Cohen R, Skup M, Ozbay AB, Rizzo J, Yang M, Diener M, Chao J. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US. J Med Econ. 2015 Jun; 18(6):447-56. PMID: 25728698.
      Citations: 29     Fields:    Translation:Humans
    85. Stein AC, Rubin DT, Hanauer SB, Cohen RD. Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease. Inflamm Bowel Dis. 2014 Oct; 20(10):1722-8. PMID: 25171509.
      Citations: 6     Fields:    Translation:Humans
    86. Stein AC, Cohen RD. Dietary fiber intake and Crohn's disease. Gastroenterology. 2014 Apr; 146(4):1133. PMID: 24576734.
      Citations: 4     Fields:    Translation:Humans
    87. Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Langholff W, Londhe A, Sandborn WJ. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry. Am J Gastroenterol. 2014 Feb; 109(2):212-23. PMID: 24394749.
      Citations: 48     Fields:    Translation:Humans
    88. Shuster D, Calabrese E, Mlynarsky L, Tumuluri S, Cohen RD, Yanai H. The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies. Inflamm Bowel Dis. 2013 Dec; 19(13):2778-86. PMID: 24185311.
      Citations: 7     Fields:    Translation:Humans
    89. Sakuraba A, Annunziata ML, Cohen RD, Hanauer SB, Rubin DT. Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease. Inflamm Bowel Dis. 2013 Nov; 19(12):2577-83. PMID: 24132161.
      Citations: 11     Fields:    Translation:Humans
    90. Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):1601-8.e1-4. PMID: 23872237; PMCID: PMC3840031.
      Citations: 104     Fields:    Translation:Humans
    91. Sakuraba A, Keyashian K, Correia C, Melek J, Cohen RD, Hanauer SB, Rubin DT. Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center. Inflamm Bowel Dis. 2013 Mar; 19(3):621-6. PMID: 23429449; PMCID: PMC4779049.
      Citations: 14     Fields:    Translation:Humans
    92. Yen L, Wu J, Hodgkins PL, Cohen RD, Nichol MB. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis. J Manag Care Pharm. 2012 Nov-Dec; 18(9):701-12. PMID: 23206213; PMCID: PMC10437351.
      Citations: 12     Fields:    Translation:Humans
    93. Mitra D, Hodgkins P, Yen L, Davis KL, Cohen RD. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. BMC Gastroenterol. 2012 Sep 24; 12:132. PMID: 23006789; PMCID: PMC3532119.
      Citations: 23     Fields:    Translation:Humans
    94. Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Price S, Langholff W, Londhe A, Sandborn WJ. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. Am J Gastroenterol. 2012 Sep; 107(9):1409-22. PMID: 22890223; PMCID: PMC3438468.
      Citations: 243     Fields:    Translation:Humans
    95. Leung Y, Kaplan GG, Rioux KP, Hubbard J, Kamhawi S, Stasiak L, Cohen RD, Devlin SM, Panaccione R, Hanauer SB, Rubin DT. Assessment of variables associated with smoking cessation in Crohn's disease. Dig Dis Sci. 2012 Apr; 57(4):1026-32. PMID: 22311366.
      Citations: 8     Fields:    Translation:Humans
    96. Cohen RD, Lewis JR, Turner H, Harrell LE, Hanauer SB, Rubin DT. Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center. Inflamm Bowel Dis. 2012 Jan; 18(1):10-6. PMID: 21456032.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    97. Oliveira L, Cohen RD. Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine. Drug Des Devel Ther. 2011 Feb 27; 5:111-6. PMID: 21448448; PMCID: PMC3063115.
      Citations: 5     Fields:    Translation:Humans
    98. Cohen RD. The pharmacoeconomics of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol. 2010 Feb; 7(2):103-9. PMID: 20134492.
      Citations: 15     Fields:    Translation:Humans
    99. Cohen RD, Yu AP, Wu EQ, Xie J, Mulani PM, Chao J. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010 Apr; 31(7):693-707. PMID: 20064142.
      Citations: 112     Fields:    Translation:Humans
    100. Afif W, Leighton JA, Hanauer SB, Loftus EV, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis. 2009 Sep; 15(9):1302-7. PMID: 19408340.
      Citations: 40     Fields:    Translation:HumansCTClinical Trials
    101. Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol. 2009 Aug; 43(7):613-6. PMID: 19142167.
      Citations: 26     Fields:    Translation:Humans
    102. Cohen RD. How should we treat severe acute steroid-refractory ulcerative colitis? Inflamm Bowel Dis. 2009 Jan; 15(1):150-1. PMID: 18844216.
      Citations: 4     Fields:    Translation:Humans
    103. Cohen RD, Waters HC, Tang B, Rahman MI. Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment. Inflamm Bowel Dis. 2008 Dec; 14(12):1707-14. PMID: 18618630.
      Citations: 20     Fields:    Translation:Humans
    104. Schwartz M, Cohen R. Optimizing conventional therapy for inflammatory bowel disease. Curr Gastroenterol Rep. 2008 Dec; 10(6):585-90. PMID: 19006615.
      Citations: 9     Fields:    Translation:Humans
    105. Cohen RD. What is the optimal maintenance treatment for ulcerative colitis? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S236-7. PMID: 18816679.
      Citations:    Fields:    Translation:HumansPHPublic Health
    106. Cohen R, Robinson D, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis. 2008 Jun; 14(6):738-43. PMID: 18300281.
      Citations: 51     Fields:    Translation:Humans
    107. Safdi AV, Cohen RD. Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates. Aliment Pharmacol Ther. 2007 Nov 01; 26(9):1179-86. PMID: 17944732.
      Citations: 3     Fields:    Translation:Humans
    108. Cohen RD, Bowie WR, Enns R, Flint J, Fitzgerald JM. Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease. Thorax. 2007 Nov; 62(11):1013-4. PMID: 17965080; PMCID: PMC2117133.
      Citations: 13     Fields:    Translation:Humans
    109. Kedia P, Cohen RD. Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis. Ther Clin Risk Manag. 2007 Oct; 3(5):919-27. PMID: 18473016; PMCID: PMC2376087.
      Citations: 6     
    110. Thomas T, Cohen RD. Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):101-12. PMID: 19072439.
      Citations:    Fields:    Translation:Humans
    111. Zisman TL, Cohen RD. Pharmacoeconomics and quality of life of current and emerging biologic therapies for inflammatory bowel disease. Curr Treat Options Gastroenterol. 2007 Jun; 10(3):185-94. PMID: 17547857.
      Citations: 4     
    112. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007 Jun; 65(7):998-1004. PMID: 17451704.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    113. Cohen RD, Thomas T. Economics of the use of biologics in the treatment of inflammatory bowel disease. Gastroenterol Clin North Am. 2006 Dec; 35(4):867-82. PMID: 17129818.
      Citations: 8     Fields:    Translation:Humans
    114. Regueiro M, Loftus EV, Steinhart AH, Cohen RD. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials. Inflamm Bowel Dis. 2006 Oct; 12(10):979-94. PMID: 17012969.
      Citations: 26     Fields:    Translation:HumansCells
    115. Regueiro M, Loftus EV, Steinhart AH, Cohen RD, Inflammatory Bowel Disease Center. Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement. Inflamm Bowel Dis. 2006 Oct; 12(10):972-8. PMID: 17012968.
      Citations: 15     Fields:    Translation:Humans
    116. Lichtenstein GR, Cohen R, Yamashita B, Diamond RH. Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol. 2006 Sep; 40(8):669-77. PMID: 16940876.
      Citations: 19     Fields:    Translation:Humans
    117. Cohen RD. Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006 Aug 01; 24(3):465-74. PMID: 16886912.
      Citations: 11     Fields:    Translation:Humans
    118. Lichtenstein GR, Sbreu MT, Cohen R, Tremaine W. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease]. Rev Gastroenterol Mex. 2006 Jul-Sep; 71(3):351-401. PMID: 17140062.
      Citations: 6     Fields:    Translation:Humans
    119. Sohi S, Cohen RD. Management of refractory ulcerative colitis. Curr Treat Options Gastroenterol. 2006 Jun; 9(3):234-45. PMID: 16901387.
      Citations: 1     
    120. Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006 May; 4(5):621-30. PMID: 16678077.
      Citations: 225     Fields:    Translation:Humans
    121. Lichtenstein GR, Olson A, Travers S, Diamond RH, Chen DM, Pritchard ML, Feagan BG, Cohen RD, Salzberg BA, Hanauer SB, Sandborn WJ. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease. Am J Gastroenterol. 2006 May; 101(5):1030-8. PMID: 16606351.
      Citations: 66     Fields:    Translation:Humans
    122. Robinson D, Hackett M, Wong J, Kimball AB, Cohen R, Bala M, IMID Study Group. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin. 2006 May; 22(5):989-1000. PMID: 16709321.
      Citations: 31     Fields:    Translation:Humans
    123. Cohen RD. MLN-02 in IBD: is "super-selective" really super? Gastroenterology. 2006 May; 130(6):1923-4. PMID: 16697759.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    124. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006 Mar; 130(3):935-9. PMID: 16530531.
      Citations: 73     Fields:    Translation:Humans
    125. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006 Mar; 130(3):940-87. PMID: 16530532.
      Citations: 128     Fields:    Translation:Humans
    126. Cohen RD. Azathioprine versus mesalamine in steroid-dependent ulcerative colitis: long-awaited results? Gastroenterology. 2006 Feb; 130(2):607-8; discussion 608. PMID: 16472614.
      Citations:    Fields:    Translation:Humans
    127. Keswani RN, Cohen RD. Postoperative management of ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep. 2005 Dec; 7(6):492-9. PMID: 16313880.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    128. Cohen RD. Worms, germs and IBD: is it your mother's fault? Gastroenterology. 2005 Sep; 129(3):1127-8; discussion 1128-9. PMID: 16143151.
      Citations:    Fields:    Translation:HumansAnimalsCells
    129. Cohen RD. Mycobacterium in Crohn's: something to ruminate about? Gastroenterology. 2005 Jun; 128(7):2167-8. PMID: 15940650.
      Citations:    Fields:    
    130. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2005 Mar 15; 21(6):733-8. PMID: 15771759.
      Citations: 45     Fields:    Translation:Humans
    131. Qureshi AI, Cohen RD. Mesalamine delivery systems: do they really make much difference? Adv Drug Deliv Rev. 2005 Jan 06; 57(2):281-302. PMID: 15555743.
      Citations: 9     Fields:    Translation:HumansAnimals
    132. Cohen RD. Treating ulcerative colitis without medications--"look mom, no drugs!". Gastroenterology. 2005 Jan; 128(1):235-6. PMID: 15633142.
      Citations: 12     Fields:    
    133. Ross AS, Cohen RD. Medical therapy for ulcerative colitis: the state of the art and beyond. Curr Gastroenterol Rep. 2004 Dec; 6(6):488-95. PMID: 15527679.
      Citations: 8     Fields:    Translation:Humans
    134. Cohen RD. Sperm, sex, and 6-MP: the perception on conception. Gastroenterology. 2004 Oct; 127(4):1263-4. PMID: 15481005.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    135. Sandborn WJ, Hanauer S, Loftus EV, Tremaine WJ, Kane S, Cohen R, Hanson K, Johnson T, Schmitt D, Jeche R. An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol. 2004 Oct; 99(10):1984-9. PMID: 15447761.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    136. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004 Sep; 127(3):723-9. PMID: 15362027.
      Citations: 103     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    137. Cohen RD. Mesalamine in IBD: multiple hats? Gastroenterology. 2004 Sep; 127(3):1001-2; discussion 1002. PMID: 15362058.
      Citations:    Fields:    
    138. Chang JC, Cohen RD. Medical management of severe ulcerative colitis. Gastroenterol Clin North Am. 2004 Jun; 33(2):235-50, viii. PMID: 15177536.
      Citations: 8     Fields:    Translation:Humans
    139. Wang HL, Shah AG, Yerian LM, Cohen RD, Hart J. Collagenous gastritis: an unusual association with profound weight loss. Arch Pathol Lab Med. 2004 Feb; 128(2):229-32. PMID: 14736276.
      Citations: 6     Fields:    Translation:Humans
    140. Cohen RD. IBD researchers reach for the "tabloid". Gastroenterology. 2004 Feb; 126(2):611-2. PMID: 14762801.
      Citations:    Fields:    
    141. Han PD, Cohen RD. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs. 2004; 64(16):1767-77. PMID: 15301561.
      Citations: 12     Fields:    Translation:Humans
    142. Cohen RD. Infliximab at 5 years--tweaking the recipe for success? Gastroenterology. 2003 Dec; 125(6):1902-3. PMID: 14724849.
      Citations:    Fields:    Translation:Humans
    143. Cohen RD. IBD indirect costs: the sleeping giant? Gastroenterology. 2003 Sep; 125(3):982-4. PMID: 12949746.
      Citations: 2     Fields:    Translation:Humans
    144. Cohen RD. Infliximab in ulcerative colitis: is there a placebo (effect) in the house? Gastroenterology. 2003 Jun; 124(7):1990-1; discussion 1991. PMID: 12806639.
      Citations: 1     Fields:    Translation:Humans
    145. Cohen RD. IBD: the drugs work...but do the patients? Am J Gastroenterol. 2003 Apr; 98(4):722-3. PMID: 12738447.
      Citations:    Fields:    Translation:Humans
    146. Cohen RD. The mesalamine wars heat up-enter balsalazide. Gastroenterology. 2003 Feb; 124(2):574-5. PMID: 12557164.
      Citations:    Fields:    Translation:Humans
    147. Cohen RD. Evolving medical therapies for ulcerative colitis. Curr Gastroenterol Rep. 2002 Dec; 4(6):497-505. PMID: 12441040.
      Citations: 4     Fields:    Translation:Humans
    148. Cohen RD. Methotrexate in IBD--move over 6-MP? Not so fast... Gastroenterology. 2002 Nov; 123(5):1737-9. PMID: 12404250.
      Citations:    Fields:    Translation:Humans
    149. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther. 2002 Sep; 16(9):1603-9. PMID: 12197839.
      Citations: 83     Fields:    Translation:Humans
    150. Rubenstein JH, Chong RY, Cohen RD. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol. 2002 Aug; 35(2):151-6. PMID: 12172361.
      Citations: 25     Fields:    Translation:Humans
    151. Lee SD, Cohen RD. Endoscopy of the small bowel in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2002 Jul; 12(3):485-93. PMID: 12486940.
      Citations: 7     Fields:    Translation:Humans
    152. Cohen RD. Forecast for using metabolite measurements in the dosing of azathioprine or 6-mercaptopurine for IBD patients: "partly cloudy". Gastroenterology. 2002 Jun; 122(7):2082-4; discussion 2084. PMID: 12078667.
      Citations: 2     Fields:    Translation:Humans
    153. Levitsky J, Harrison JR, Cohen RD. Crohn's disease and Takayasu's arteritis. J Clin Gastroenterol. 2002 Apr; 34(4):454-6. PMID: 11907362.
      Citations: 9     Fields:    Translation:Humans
    154. Cohen RD. Cost utility of initial medical management for Crohn's disease perianal fistula. Gastroenterology. 2002 Apr; 122(4):1187-8; author reply 1188-90. PMID: 11910380.
      Citations: 2     Fields:    Translation:Humans
    155. Lee SD, Cohen RD. Endoscopy in inflammatory bowel disease. Gastroenterol Clin North Am. 2002 Mar; 31(1):119-32. PMID: 12122727.
      Citations: 7     Fields:    Translation:Humans
    156. Baron BW, Jeon HR, Glunz C, Peterson A, Cohen R, Hanauer S, Rubin D, Hart J, Baron JM. First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange. J Clin Apher. 2002; 17(4):204-6. PMID: 12494414.
      Citations: 2     Fields:    Translation:Humans
    157. Cohen RD. Infliximab as first-line therapy for severe Crohn's disease? Inflamm Bowel Dis. 2002 Jan; 8(1):58-9; discussion 63-5. PMID: 11837940.
      Citations: 1     Fields:    Translation:Humans
    158. Chung PY, Cohen RD. Evolving medical therapies for ulcerative colitis. Curr Gastroenterol Rep. 2001 Dec; 3(6):464-70. PMID: 11696283.
      Citations:    Fields:    Translation:Humans
    159. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001 Oct; 96(10):2929-33. PMID: 11693328.
      Citations: 108     Fields:    Translation:Humans
    160. Cohen RD. Intravenous cyclosporine in severe ulcerative colitis: ready to stand alone? Gastroenterology. 2001 May; 120(6):1541-3. PMID: 11313325.
      Citations: 5     Fields:    Translation:Humans
    161. Cohen RD. Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience. Inflamm Bowel Dis. 2001 May; 7 Suppl 1:S17-22. PMID: 11380038.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    162. Chong RY, Hanauer SB, Cohen RD. Efficacy of parenteral methotrexate in refractory Crohn's disease. Aliment Pharmacol Ther. 2001 Jan; 15(1):35-44. PMID: 11136276.
      Citations: 14     Fields:    Translation:Humans
    163. Cohen RD, Tsang JF, Hanauer SB. Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol. 2000 Dec; 95(12):3469-77. PMID: 11151879.
      Citations: 33     Fields:    Translation:Humans
    164. Cohen RD. The cost of Crohn's disease: drugs or surgery? BioDrugs. 2000 Nov; 14(5):331-44. PMID: 18034577.
      Citations:    Fields:    
    165. Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol. 2000 May; 95(5):1263-76. PMID: 10811338.
      Citations: 51     Fields:    Translation:Humans
    166. Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn's disease. Am J Gastroenterol. 2000 Feb; 95(2):524-30. PMID: 10685762.
      Citations: 45     Fields:    Translation:Humans
    167. Hurst RD, Cohen RD. The role of laparoscopy and strictureplasty in the management of inflammatory bowel disease. Semin Gastrointest Dis. 2000 Jan; 11(1):10-7. PMID: 10706225.
      Citations: 2     Fields:    Translation:Humans
    168. Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanauer SB. Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology. 1999 Dec; 117(6):1271-7. PMID: 10579967.
      Citations: 47     Fields:    Translation:HumansCTClinical Trials
    169. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia. 1999 Aug; 42(Suppl 1):A1-A330. PMID: 27770183.
      Citations: 8     Fields:    
    170. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol. 1999 Jun; 94(6):1587-92. PMID: 10364029.
      Citations: 68     Fields:    Translation:Humans
    171. Cohen RD. Validation of health-related quality of life instruments. Hepatology. 1999 Jun; 29(6 Suppl):7S-8S. PMID: 10386075.
      Citations: 3     Fields:    Translation:Humans
    172. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis. 1999 Feb; 5(1):1-10. PMID: 10028443.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    173. Hanauer SB, Cohen RD, Becker RV, Larson LR, Vreeland MG. Advances in the management of Crohn's disease: economic and clinical potential of infliximab. Clin Ther. 1998 Sep-Oct; 20(5):1009-28. PMID: 9829451.
      Citations: 9     Fields:    Translation:Humans
    174. Wallhagen MI, Strawbridge WJ, Cohen RD, Kaplan GA. An increasing prevalence of hearing impairment and associated risk factors over three decades of the Alameda County Study. Am J Public Health. 1997 Mar; 87(3):440-2. PMID: 9096550; PMCID: PMC1381021.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    175. Cohen RD, Hanauer SB. Protection from primary sclerosing cholangitis: smoke trails of just coattails? Gastroenterology. 1996 May; 110(5):1658-62. PMID: 8613079.
      Citations: 2     Fields:    Translation:Humans
    176. Cohen RD, Hanauer SB. Surveillance colonoscopy in ulcerative colitis: is the message loud and clear? Am J Gastroenterol. 1995 Dec; 90(12):2090-2. PMID: 8540493.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    177. Wallhagen MI, Strawbridge WJ, Kaplan GA, Cohen RD. Impact of internal health locus of control on health outcomes for older men and women: a longitudinal perspective. Gerontologist. 1994 Jun; 34(3):299-306. PMID: 8076870.
      Citations: 6     Fields:    Translation:Humans
    178. Heimann TM, Cohen RD, Szporn A, Gil J. Correlation of nuclear morphometry and DNA ploidy in rectal cancer. Dis Colon Rectum. 1991 Jun; 34(6):449-54. PMID: 2036923.
      Citations: 4     Fields:    Translation:HumansCells
    179. Wingard DL, Cohn BA, Kaplan GA, Cirillo PM, Cohen RD. Sex differentials in morbidity and mortality risks examined by age and cause in the same cohort. Am J Epidemiol. 1989 Sep; 130(3):601-10. PMID: 2764004.
      Citations: 22     Fields:    Translation:Humans
    180. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc. 1980 Mar; 55(3):146-55. PMID: 6101626.
      Citations: 36     Fields:    Translation:Humans
    Cohen's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (415)
    Explore
    _
    Co-Authors (37)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _